Skip to main content
Top

Breast Cancer Research

Issue Special Issue 2/2000

Symposium Mammographicum 2000

Content (69 Articles)

Meeting abstract

MR-guided breast biopsy

SH Heywang-Köbrunner, H Sittek, X Prat, L Baath

Meeting abstract

Lymph node diagnosis

RE Mansel

Meeting abstract

Surgical management

JM Dixon

Meeting abstract

Pre-operative diagnosis and staging of symptomatic breast disease using 99mtechnitium scintimammography

I Bradford, A Mackie, E McCauley, P Cadigan, A Cook

Meeting abstract

The evaluation of four small-field digital mammography systems

CP Lawinski, D Smith, DS Evans, A Mackenzie, NSA Wells, D Emerton, CA Lewis

Meeting abstract

A comparative evaluation of two full-field digital mammography units

D Smith, CP Lawinski, A Mackenzie, DS Evans, NSA Wells, D Emerton, CA Lewis

Meeting abstract

How do radiographers compare to radiologists when double reading screening mammograms

J Inglis, J Curtis, C Eve, G Wivell, E Denton, G Hurst

Meeting abstract

Stages of screen-detected breast cancer

K Koufopoulos, I Garas, Ch Pateras, E Ampatzoglou, P Kakavoulis, A Michas, S Gravas, V Sarrou, D Tsitsimelis, M Tsompanlioti, N Papageorgiou, K Kapridaki, F De Waard

Meeting abstract

Can radiographers reliably read screening mammograms?

G Wivell, I Harvey, J Curtin, E Denton

Meeting abstract

The lateral arm for stereotactic biopsy: how good is it?

E Denton, G Hurst, M Shaw

Meeting abstract

Sclerosing lymphocytic lobulitis (SLL): a diagnostic challenge

S Dutta, L Campbell, RM Watkins, C Teasdale, DM Lee, PA Jones

Meeting abstract

Breast ultrasound in a "moderate risk" population

D O'Driscoll, R Warren, J MacKay, P Britton, NE Day

Meeting abstract

Full-field digital mammography

U Bick

Meeting abstract

Computer aided detection

PM Taylor

Meeting abstract

Comments from a breast clinician

EMC Denton

Meeting abstract

Comments from radiologists

JA Fielding

Meeting abstract

Implanted markers prior to neoadjuvant chemotherapy: preliminary report

DM Allan for the Dartford Breast Care Team

Meeting abstract

Up the creek without a paddle

G Baxter

Meeting abstract

Techniques and equipment in mammography - an aid to diagnosis

J Berry-Smith, L Gustard

Meeting abstract

Image blur: back to basics

J Berry-Smith, C Lonsdale

Meeting abstract

Between four walls: what level of privacy do women want?

M Brown, B Caswell, M Heath

Meeting abstract

Technical recalls (TC): a lesser service?

B Caswell, V Gilks

Meeting abstract

A trial of duplicating film for mammography

GR Clough

Meeting abstract

Latent image fade and Kodak MinR2000 film

A Cowley, V Gilks

Meeting abstract

Galactocele in a postmenopausal woman: a case report

PK Dave, SB Bhaduri, S Gupta, R Nichlani, B Sanyal

Meeting abstract

Flexible screening clinics: future options

SA Dyson, VA Milnes

Meeting abstract

Decubitus positioning for stereotactic core biopsy

CE Ingram, S Nutton, S Dunhill

Meeting abstract

Pictorial essay of fat necrosis

A Murphy, JR Smales

Meeting abstract

Galactoductography

MN Mwangi

Meeting abstract

What is the predictive value for malignancy of radiological classification for indeterminate microcalcification seen on mammography?

G Ralleigh, E Sanderson, GA Berjawi, MJ Michell, S Bose, S Henderson

Meeting abstract

Scenic screening sites of Sussex

V Repose

Meeting abstract

Investigation into possible causes of blurring in mammograms

D Seddon, KA Schofield, CA Waite

Meeting abstract

Quality management systems: the benefits of achieving ISO 9002

M Wheaton, S Munslow, MG Wallis

Meeting abstract

Future of breast cancer services

Y Cooper

Meeting abstract

Future of breast cancer services

M Richards

Meeting abstract

Oncology

I Smith

Meeting abstract

Upright digital stereotaxis

A Evans

Meeting abstract

Minimally invasive treatment of the breast

M Hall-Craggs

Meeting abstract

An overview of workforce issues

H Gwynn

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine